SCHEMBL657503

SCHEMBL657503

CCOC(=O)CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.57
TSHR P16473 2/20 0.44
TP53 P04637 2/20 0.44
ALOX5 P09917 1/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LTA4H P09960 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CNR2 P34972 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
OPRM1 P35372 2/20 0.41
OPRD1 P41143 2/20 0.41
OPRK1 P41145 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL657395 0.87 SMN1; SMN2 (0.61) SMN1; SMN2TSHRTP53ALOX5MEN1
SCHEMBL658329 0.85 HDAC3 (0.49) SMN1; SMN2TSHRTP53HTTMEN1
SCHEMBL657957 0.85 SMN1; SMN2 (0.66) SMN1; SMN2TP53ALOX5MEN1KMT2A
SCHEMBL2364902 0.85 CNR2 (0.48) SMN1; SMN2TSHRTP53HTTMEN1
SCHEMBL657354 0.81 SMN1; SMN2 (0.56) SMN1; SMN2TSHRTP53ALOX5ALDH1A1
SCHEMBL656732 0.80 CNR2 (0.58) SMN1; SMN2TSHRALDH1A1CNR2GAA
SCHEMBL21821644 0.77 SMN1; SMN2 (0.73) SMN1; SMN2TSHRTP53ALOX5MEN1
SCHEMBL31441301 0.77 TSHR (0.60) SMN1; SMN2TSHRHTTALDH1A1LMNA
SCHEMBL2646637 0.77 TSHR (0.60) SMN1; SMN2TSHRHTTALDH1A1LMNA
SCHEMBL9484509 0.76 CNR2 (0.44) SMN1; SMN2TSHRALOX5HTTLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB SMN1; SMN2 4389/4885TSHR 3221/4885TP53 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.